Jeffrey B. Butler - Nov 10, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: Director
Signature: /s/ Thomas Bartrum, as attorney-in-fact
Stock symbol: PRVA
Transactions as of: Nov 10, 2022
Transactions value $: -$534,044
Form type: 4
Date filed: 11/15/2022, 05:14 PM
Previous filing: Nov 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$531K	-19.9K	-0.72%	$26.70	2.73M	Nov 10, 2022	Direct	F1, F2
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$2.71K	-100	0%	$27.14	2.73M	Nov 10, 2022	Direct	F1
holding	PRVA	Common Stock, $0.01 par value per share						870K	Nov 10, 2022	Held indirectly through Butler Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jeffrey B. Butler is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.14 to $27.11 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.14 to $27.11 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.